Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-26-033380
Filing Date
2026-07-15
Accepted
2026-07-15 16:46:03
Documents
75
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1167557
2 EX-31.1 ex31-1.htm EX-31.1 17379
3 EX-31.2 ex31-2.htm EX-31.2 17412
4 EX-32.1 ex32-1.htm EX-32.1 7397
5 EX-32.2 ex32-2.htm EX-32.2 7699
  Complete submission text file 0001493152-26-033380.txt   6867814

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdt-20260331.xsd EX-101.SCH 63281
7 XBRL CALCULATION FILE cdt-20260331_cal.xml EX-101.CAL 65108
8 XBRL DEFINITION FILE cdt-20260331_def.xml EX-101.DEF 275483
9 XBRL LABEL FILE cdt-20260331_lab.xml EX-101.LAB 491995
10 XBRL PRESENTATION FILE cdt-20260331_pre.xml EX-101.PRE 379055
78 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 966029
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CDT Equity Inc. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41245 | Film No.: 261177864
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)